Development and validation of the Decisional Balance Scale for problematic Prescription Drug use (DBS-PD)-20

Sabine I. Braun*, Gallus Bischof, Hans Jürgen Rumpf

*Corresponding author for this work
1 Citation (Scopus)

Abstract

The purpose of this study was to develop a Decisional Balance Scale (DBS) for Prescription Drugs (PD), the DBS-PD-20, to examine its factorial structure and test its reliability and external validity by comparison across Stages of Change. A sample of 126 general hospital inpatients with either regular use of PD (more than 60. days within the last three months) or abuse of or dependence on PD was recruited in a northern German city. Exploratory principal components analysis revealed a two-factor structure, the Pros and Cons of PD intake, as expected. While the DBS-PD-20 showed good reliability (Cronbach's alpha = 0.91 for the Pros and = 0.89 for the Cons), external validity could be proven for the Cons (significant increase from precontemplation to contemplation/action), whereas the Pros showed an insignificant increase. Although further validation is needed, the DBS-PD-20 may be helpful for interventions and research.

Original languageEnglish
JournalAddictive behaviors
Volume37
Issue number4
Pages (from-to)444-448
Number of pages5
ISSN0306-4603
DOIs
Publication statusPublished - 04.2012

Research Areas and Centers

  • Academic Focus: Center for Brain, Behavior and Metabolism (CBBM)

Fingerprint

Dive into the research topics of 'Development and validation of the Decisional Balance Scale for problematic Prescription Drug use (DBS-PD)-20'. Together they form a unique fingerprint.

Cite this